MeCy is Cyclomics' groundbreaking technology for CpG island methylation analysis, offering a simpler, more efficient approach by eliminating the need for traditional bisulfite conversion. This patent-pending technology preserves the integrity of the DNA while delivering high-accuracy methylation profiles without the harsh chemical treatments typically required. MeCy is compatible with both long-read and short-read sequencing platforms, making it versatile for various research and clinical applications. Additionally, MeCy goes beyond just methylation analysis—it provides single nucleotide polymorphism (SNP) and copy number variation (CNV) data in a single sequencing run, offering comprehensive insights into genomic and epigenomic alterations.

​

Key Features:

Efficient and Accurate: By eliminating bisulfite conversion, MeCy simplifies the workflow, reduces DNA damage, and produces more reliable methylation data.

Platform Compatibility: MeCy works seamlessly with both long-read platforms like Nanopore sequencing and short-read platforms like Illumina, giving researchers flexibility based on their preferred technology.

Comprehensive Data in One Run: MeCy simultaneously detects SNPs, CNVs, and methylation patterns, offering an integrated solution for understanding complex genetic and epigenetic changes.